Bernstein on Medtronic, Inc. (MDT): 'Positive Momentum; We Like the Diabetes Split-Off'
Tweet Send to a Friend
Bernstein SocGen Group analyst Lee Hambright reiterated an Outperform rating and $93.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
